Athersys Inc - Company Profile
Powered by 
All the data and insights you need on Athersys Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Athersys Inc Strategy Report
- Understand Athersys Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Athersys Lead Sheet
Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Athersys Inc’s relevant decision makers and contact details.
A sample of Athersys Lead Sheet data
| Lead Date | Lead Type | Lead Description | Company Name | Drug Name | Therapy Area |
|---|---|---|---|---|---|
| 09 Jan 2023 | GDCTWXYZ | Lorem | Lorem | Lorem | Cardiovascular |
| 06 Jan 2023 | New Appointment | Joseph Nolan appointed as Director, Member of the Board | Athersys Inc | - | - |
| 10 Nov 2022 | Capital Raisings | Athersys Raises USD5.5 Million in Public Offering of Common Stock | Athersys Inc | invimestrocel; Small Molecule to Antagonize H3 Receptor for Cognitive Disorders; Small Molecules to Agonize 5-HT2C for Obesity and Schizophrenia | Cardiovascular; Central Nervous System; Gastrointestinal; Genetic Disorders; Immunology; Infectious Disease; Metabolic Disorders; Oncology; Other Diseases; Respiratory |
| 07 Nov 2022 | Capital Raisings | Athersys to Raise Funds through Public Offering of Common Stock | Athersys Inc | invimestrocel; Small Molecule to Antagonize H3 Receptor for Cognitive Disorders; Small Molecules to Agonize 5-HT2C for Obesity and Schizophrenia | Cardiovascular; Central Nervous System; Gastrointestinal; Genetic Disorders; Immunology; Infectious Disease; Metabolic Disorders; Oncology; Other Diseases; Respiratory |
Feature
Lead Sheet offers business development users in a Supplier Company, convenient access to leads within the biopharmaceutical industry.
- Lead: Any current or future events that signal a company may need services from another company in the near future.
Depending on the user’s company type, specific events may be considered a lead for the goods or services they provide.
Benefit
Leads within Lead Sheet fall into six major types of occurrences: Trial Events, Regulatory Events, Deals, Insights, New Companies, and Role Changes.
Some of these categories are broken out further to allow users the flexibility to filter to the event types they consider a lead.
Any lead type starting with “Expected” implies that it is a future event sourced from our Catalyst Calendar.
Value
Lead Sheet is a business development tool to help optimize sales efficiency
- What prospective accounts to target
- When and why to target them through actionable leads/opportunities
- Who to reach out to
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer